2.68
price up icon11.67%   0.28
after-market アフターアワーズ: 2.74 0.06 +2.24%
loading
前日終値:
$2.40
開ける:
$2.44
24時間の取引高:
53,769
Relative Volume:
6.91
時価総額:
$15.32M
収益:
$105.38M
当期純損益:
$17.78M
株価収益率:
1.0037
EPS:
2.67
ネットキャッシュフロー:
$-50.48M
1週間 パフォーマンス:
-0.37%
1か月 パフォーマンス:
+24.65%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
-4.96%
1日の値動き範囲:
Value
$2.37
$2.68
1週間の範囲:
Value
$2.32
$3.15
52週間の値動き範囲:
Value
$1.46
$4.10

Mei Pharma Inc Stock (MEIP) Company Profile

Name
名前
Mei Pharma Inc
Name
セクター
Healthcare (1160)
Name
電話
858-369-7100
Name
住所
11455 EL CAMINO REAL, SAN DIEGO, CA
Name
職員
28
Name
Twitter
@MEI_Pharma
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
MEIP's Discussions on Twitter

MEIP を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MEIP
Mei Pharma Inc
2.68 15.32M 105.38M 17.78M -50.48M 2.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Mei Pharma Inc Stock (MEIP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-07-23 ダウングレード Laidlaw Buy → Hold
2022-03-25 ダウングレード Jefferies Buy → Hold
2022-03-25 ダウングレード Stifel Buy → Hold
2022-03-25 ダウングレード Wells Fargo Overweight → Equal Weight
2022-02-03 開始されました Jefferies Buy
2020-09-22 開始されました Alliance Global Partners Buy
2020-05-29 開始されました SunTrust Buy
2018-12-20 開始されました H.C. Wainwright Buy
2018-07-27 アップグレード Stifel Hold → Buy
2018-07-13 開始されました SunTrust Buy
2016-04-18 繰り返されました Wedbush Neutral
2015-03-23 ダウングレード ROTH Capital Buy → Neutral
2014-12-18 繰り返されました ROTH Capital Buy
2014-10-16 繰り返されました ROTH Capital Buy
2014-07-08 再開されました Brean Capital Buy
2013-10-22 繰り返されました Stifel Buy
2013-04-15 開始されました Stifel Buy
すべてを表示

Mei Pharma Inc (MEIP) 最新ニュース

pulisher
Jun 12, 2025

MEI Pharma (NASDAQ:MEIP) Shares Cross Below Two Hundred Day Moving Average – What’s Next? - Defense World

Jun 12, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Increases Stock Holdings in MEI Pharma, Inc. (NASDAQ:MEIP) - Defense World

Jun 04, 2025
pulisher
May 21, 2025

Marginal Zone Lymphoma Pipeline Appears Robust With 50+ Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail

May 21, 2025
pulisher
May 18, 2025

MEI Pharma (NASDAQ:MEIP) Coverage Initiated at StockNews.com - Defense World

May 18, 2025
pulisher
May 16, 2025

1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid - The Globe and Mail

May 16, 2025
pulisher
May 15, 2025

MEI Pharma Reports Significant Revenue Decline - TipRanks

May 15, 2025
pulisher
May 14, 2025

MEIP Explores Strategic Options to Enhance Shareholder Value | M - GuruFocus

May 14, 2025
pulisher
May 14, 2025

MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position - GuruFocus

May 14, 2025
pulisher
May 10, 2025

MEI Pharma (NASDAQ:MEIP) Earns Buy Rating from Analysts at StockNews.com - Defense World

May 10, 2025
pulisher
May 04, 2025

This More Than 5%-Yielding Dividend Stock Looks Like a Can't-Miss Buy for Income and Upside Potential - The Globe and Mail

May 04, 2025
pulisher
May 02, 2025

A new MEI study highlights the importance of micro-entrepreneurs in supplying drinking water to poorer neighbourhoods in Ivory Coast - GlobeNewswire Inc.

May 02, 2025
pulisher
May 02, 2025

10 Best NASDAQ Stocks to Buy According to Billionaires - Insider Monkey

May 02, 2025
pulisher
May 02, 2025

Inside Buffett’s $334B Cash Pile: Get Ready for Berkshire Hathaway Earnings - The Globe and Mail

May 02, 2025
pulisher
May 02, 2025

MEI Pharma (NASDAQ:MEIP) Now Covered by StockNews.com - Defense World

May 02, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 24, 2025

StockNews.com Initiates Coverage on MEI Pharma (NASDAQ:MEIP) - Defense World

Apr 24, 2025
pulisher
Apr 22, 2025

Follicular Lymphoma Treatment Market 2034: EMA, PDMA, FDA - openPR.com

Apr 22, 2025
pulisher
Apr 22, 2025

Follicular Lymphoma Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Medication, Prevalence, Revenue, Statistics and Companies by DelveInsight - The Globe and Mail

Apr 22, 2025
pulisher
Apr 21, 2025

Sharp Co. (OTCMKTS:SHCAY) Short Interest Down 25.8% in March - The AM Reporter

Apr 21, 2025
pulisher
Apr 17, 2025

11 Best Internet Retail Stocks to Buy According to Analysts - Insider Monkey

Apr 17, 2025
pulisher
Apr 17, 2025

Billionaire David Tepper’s Top 10 Stock Picks - Insider Monkey

Apr 17, 2025
pulisher
Apr 16, 2025

MEI Pharma (NASDAQ:MEIP) Stock Passes Below Two Hundred Day Moving Average – Here’s What Happened - Defense World

Apr 16, 2025
pulisher
Apr 09, 2025

MEI Pharma stock hits 52-week low at $1.83 amid market challenges - Investing.com

Apr 09, 2025
pulisher
Apr 08, 2025

MEI Pharma stock hits 52-week low at $1.83 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 04, 2025

MEI PHARMA INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus

Apr 04, 2025
pulisher
Apr 02, 2025

Follicular Lymphoma Market to Reach New Heights in Growth - openPR.com

Apr 02, 2025
pulisher
Apr 02, 2025

Follicular Lymphoma Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Roche, BeiGene, Kite Pharma, Incyte Corp, AstraZeneca, MEI Pharma, Novartis, Innovent Biologics, Regeneron - Barchart.com

Apr 02, 2025
pulisher
Apr 02, 2025

Virtu Financial LLC Purchases Shares of 10,744 MEI Pharma, Inc. (NASDAQ:MEIP) - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

MEI Pharma (NASDAQ:MEIP) Now Covered by Analysts at StockNews.com - The AM Reporter

Apr 01, 2025
pulisher
Mar 31, 2025

StockNews.com Begins Coverage on MEI Pharma (NASDAQ:MEIP) - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

MEI Pharma stock hits 52-week low at $2.27 amid market challenges - Investing.com Australia

Mar 28, 2025
pulisher
Mar 26, 2025

The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors - Business Wire

Mar 26, 2025
pulisher
Mar 23, 2025

MEI Pharma (NASDAQ:MEIP) Coverage Initiated by Analysts at StockNews.com - Defense World

Mar 23, 2025
pulisher
Mar 18, 2025

MEI Pharma stock hits 52-week low at $2.28 amid market challenges - Investing.com Australia

Mar 18, 2025
pulisher
Mar 17, 2025

MEI Pharma stock hits 52-week low at $2.28 amid market challenges By Investing.com - Investing.com South Africa

Mar 17, 2025
pulisher
Mar 12, 2025

Will the Stock Market Crash As President Trump's Tariffs Take Effect? History Offers a Clue. - The Globe and Mail

Mar 12, 2025
pulisher
Mar 07, 2025

MEI Pharma, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 06, 2025

10 Cheap Chinese Stocks to Buy Now - Insider Monkey

Mar 06, 2025
pulisher
Mar 05, 2025

11 Best Undervalued Stocks to Invest in Now - Insider Monkey

Mar 05, 2025
pulisher
Feb 27, 2025

The Polycythemia Vera Market Landscape Heats Up Amid Rising Competition Among Pharma Companies | DelveInsight - The Malaysian Reserve

Feb 27, 2025
pulisher
Feb 24, 2025

Cautious Investors Should Wait for THIS Entry Point Before Buying Nvidia Stock - The Globe and Mail

Feb 24, 2025
pulisher
Feb 19, 2025

C-COM Antenna Receives Eutelsat Type Approval - The Globe and Mail

Feb 19, 2025
pulisher
Feb 19, 2025

Marginal Zone Lymphoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Feb 19, 2025
pulisher
Feb 19, 2025

Alarm.com (ALRM) Q4 Earnings: What To Expect - The Globe and Mail

Feb 19, 2025
pulisher
Feb 19, 2025

Why Tight Corporate-U.S. Treasury Yield Spreads Signal Good News for Ag Markets Prices - The Globe and Mail

Feb 19, 2025
pulisher
Feb 13, 2025

MEI Pharma Reports Increased Losses Amid Strategic Shift - TipRanks

Feb 13, 2025

Mei Pharma Inc (MEIP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
大文字化:     |  ボリューム (24 時間):